Full-Time
SaaS platform optimizing MedTech commercial strategy
$140k - $190k/yr
No H1B Sponsorship
Remote in USA + 1 more
More locations: Boston, MA, USA
Remote
Remote within the United States, with 4–5 in-person company or team on-sites per year.
See people who can refer or advise you
AcuityMD offers a SaaS platform for the MedTech industry to identify target markets, surface top opportunities, and grow revenue across the product lifecycle. It turns large healthcare data into intuitive workflows that align sales and marketing with the overall commercial process. The platform includes market research, growth opportunity spotting, and sales strategy optimization available by subscription. Its goal is to improve market focus and accelerate revenue growth, helping medical devices reach patients faster.
Company Size
201-500
Company Stage
Series C
Total Funding
$163M
Headquarters
Boston, Massachusetts
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Flexible Work Hours
Unlimited Paid Time Off
Paid Health, Dental, and Vision Plans
Home Office Stipend
Learning Budget
Parental Leave
Company Equity
Optional Team Retreats
AcuityMD, an AI platform for the medical technology industry, has been named to the 2026 Inc. 5000 list at No. 316. The Boston-based company achieved 1,061% three-year revenue growth, roughly 10 times the median rate among honorees. Sixteen of the top 20 medical device companies use AcuityMD to identify target markets and prioritise physicians. The platform has helped over 500 customers identify more than $34 billion in pipeline. In April, AcuityMD announced $80 million in new funding and launched AcuityAI, purpose-built AI tools for MedTech commercial teams. The company has raised upwards of $160 million and is valued at $955 million. This marks AcuityMD's first appearance on the prestigious annual ranking.
AcuityMD ranked No. 316 on the 2026 Inc. 5000 list, the most prestigious ranking of America's fastest-growing private companies. August 12, 2026 MedTech AI leader recognized for 1,061% three-year revenue growth - topping the software category at no. 28 - and now valued at $955 million BOSTON - August 12, 2026 - AcuityMD, the AI platform for MedTech, today announced it has been named to the 2026 Inc. 5000 list of the fastest-growing private companies in America. AcuityMD ranked No. 316, driven by 1,061% three-year revenue growth - roughly 10 times the median revenue growth rate of 130% among 2026 Inc. 5000 honorees. The company also ranked No. 28 out of 362 software companies on the list. This marks AcuityMD's first appearance on Inc. Magazine's prestigious annual ranking. The Inc. 5000 ranks the nation's most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, and Oracle. AcuityMD is one of a few software companies on the list focused on the MedTech industry. "We're proud to be recognized by Inc., but what matters most is what's behind the growth: customers choosing AcuityMD to help them make better commercial decisions," said Mike Monovoukas, CEO & Co-Founder of AcuityMD. "This milestone is a reflection of our team and our customers, and we're excited to keep raising the bar for how AI can help accelerate the adoption of medical technology." Today, 16 out of the top 20 medical devices (MedTech) companies rely on AcuityMD to identify target markets, prioritize high-value physicians, and accelerate revenue growth. Their adoption underscores the growing role of AI in helping MedTech commercial teams navigate an increasingly complex market and make faster, more informed decisions. In April, AcuityMD announced $80 million in new funding to elevate its platform with advanced AI capabilities. With the launch of AcuityAI, MedTech commercial teams now have purpose-built AI at their fingertips designed for their unique industry challenges. The platform combines rich domain expertise, data that maps relationships between sites of care and healthcare providers, and unique selling context to support specific MedTech commercial workflows. AcuityMD currently supports more than 500 customers and has helped these customers identify over $34 billion in pipeline. The company has raised upwards of $160 million and is valued at $955 million. "Every company on the Inc. 5000 has a story of perseverance, smart decision-making, and a refusal to sit still," says Mike Hofman, editor-in-chief of Inc. "Their growth reflects more than strong financial performance-it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement." For the full Inc. 5000 list, honoree company profiles, and a searchable database, visit: www.inc.com/inc5000. View AcuityMD's profile from the list. Inc. 5000 list methodology. Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent - not subsidiaries or divisions of other companies - as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About AcuityMD. AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies - including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Media contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413
AcuityMD now trusted by more than 500 medical device companies, including 16 of top 20. July 22, 2026 Rapid growth reflects seismic shift toward greater use of AI across the MedTech industry BOSTON - July 22, 2026 - AcuityMD, the AI platform for MedTech, today announced it is now trusted by more than 500 medical device (MedTech) companies, including 16 of the top 20, such as Becton Dickinson, Olympus, and Teleflex. The milestone reflects a growing shift across the medical device industry, as commercial teams adopt AI to better understand where care is happening and to uncover new opportunities. Across its customer base, AcuityMD has helped commercial teams generate billions in pipeline opportunities in the past year alone. Now, with AcuityAI, the company expects even faster growth and adoption of AI. MedTech companies face mounting pressure to launch innovations in an increasingly complex healthcare market. Physician movement, shifting sites of care, the growth of Ambulatory Surgical Centers (ASCs), hospital consolidation, and evolving reimbursement policies are constantly reshaping commercial opportunities. No company can track these changes alone. AcuityMD solves this challenge by bringing together the commercial context that's fragmented across dozens of internal and external data sources. Through its proprietary MedTech ontology - which maps physicians, facilities, health systems, products, contracts, and reimbursement dynamics - AcuityMD gives commercial teams a unified and continuously updated view of the healthcare market. With AcuityAI, teams can ask questions in natural language and receive AI-powered recommendations grounded in real-world market data, identify target markets, prioritize high-value physicians, and uncover opportunities that would otherwise take hours to find. Those insights quickly translate into action. AcuityAI has already helped customers generate thousands of accurate call plans, saving sales reps roughly 180 hours of preparation time each year - the equivalent of about a month's worth of work. "What makes this milestone meaningful is not the number itself, but rather the impact our customers are creating with the platform," said Lee Smith, AcuityMD Co-founder and Vice President of Customer Experience. "As AI becomes a bigger part of how MedTech companies operate, we are committed to enabling our customers to make smarter commercial decisions. We will continue investing in AI so our growing customer community can identify the best opportunities faster, and drive stronger results." In related news, AcuityMD just released a new report, AI Adoption in MedTech Sales: 2026 Industry Benchmarks and Trends, revealing MedTech sales reps who use AI are three times more likely to meet or exceed quota than those who do not. The report also shows that among AI users, 92% reported saving at least four hours each week. Yet, most reps only use AI for tactical tasks - less than two out of ten reps currently use AI for account research, despite the strategic value. About AcuityMD. AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies - including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Media contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413 [email protected]
AcuityMD has launched its Encounters Data Mart on Snowflake Marketplace, providing medical technology organisations with insights into procedure volumes, provider activity and healthcare delivery locations across the United States. The data mart enables MedTech companies to integrate encounter intelligence directly into their Snowflake environment, supporting commercial and strategy teams with analytics. Customers can allocate up to 25% of their Snowflake Capacity commitment to purchase the product, streamlining procurement. AcuityMD, which serves over 500 MedTech companies including 16 of the top 20, was named to Forbes' 2025 "Next Billion-Dollar Startups" list. The platform combines real-world healthcare data with AI-powered insights to help commercial teams identify target markets and growth opportunities.
AcuityMD launches the AcuityMD Encounters Data Mart on Snowflake Marketplace. Joint customers can access MedTech procedure and provider data directly within Snowflake with the AcuityMD Encounters Data Mart BOSTON-(BUSINESS WIRE)-AcuityMD today announced that it has launched the AcuityMD Encounters Data Mart on Snowflake Marketplace. The AcuityMD Encounters Data Mart provides MedTech organizations with insights into procedure volumes, provider activity, and healthcare delivery locations across the United States, enabling joint customers to quantify market opportunity and identify high-value providers and sites of care. With AcuityMD Encounters Data Mart available on Snowflake Marketplace, customers can seamlessly integrate encounter-level insights into their existing data foundation and accelerate commercial and strategic analytics. Share "MedTech organizations rely on clear visibility into where procedures occur and which providers perform them to make informed commercial decisions," said Alex Wakefield, Chief Revenue Officer at AcuityMD. "By making the AcuityMD Encounters Data Mart available on Snowflake Marketplace, teams can integrate MedTech encounter intelligence into their Snowflake environment and power analytics across commercial and strategy teams." AcuityMD and Snowflake, the AI Data Cloud company, are working together to help joint customers inform business decisions and drive innovation by delivering MedTech encounter, provider, and site-of-care data within the Snowflake AI Data Cloud. With the AcuityMD Encounters Data Mart available in Snowflake, teams across commercial, strategy, and analytics functions can enrich their existing data models with MedTech encounter insights. Customers can also allocate up to 25% of their Snowflake Capacity commitment to purchase the AcuityMD Encounters Data Mart on Snowflake Marketplace, streamlining procurement and maximizing the value of their existing Snowflake investment. "Access to timely, high-quality healthcare data is critical for MedTech organizations looking to identify opportunity and drive growth," said Todd Crosslin, Global Industry Principal Healthcare and Life Sciences, Snowflake. "With AcuityMD Encounters Data Mart available on Snowflake Marketplace, customers can seamlessly integrate encounter-level insights into their existing data foundation and accelerate commercial and strategic analytics. We're excited to support AcuityMD in bringing this capability to the Snowflake ecosystem." Joint customers can now leverage the AcuityMD Encounters Data Mart on Snowflake Marketplace, allowing them to embed procedure and provider intelligence directly into their analytics environment. About AcuityMD AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies - including 16 of the top 20. Commercial teams use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Contacts. Media Contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413 [email protected] More News From AcuityMD BOSTON-( BUSINESS WIRE )-AcuityMD, the AI platform for MedTech, today announced $80 million in new funding to elevate its platform with advanced artificial intelligence (AI) capabilities and drive the company's mission of accelerating adoption of medical technology. The Series C round was led by existing investor StepStone Group, with additional participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. Now supporting 16 of the top 20 MedTech companies and having helped c... BOSTON-( BUSINESS WIRE )-AcuityMD, the intelligence platform for MedTech, announced data revealing increased access to colorectal screening and early treatment at ambulatory surgery centers (ASCs). Across the U.S., the majority of all endoscopic colorectal procedures are now performed in ASCs, lowering barriers to care for patients who might delay or avoid screening. ASCs handled nearly 9 million endoscopic colorectal procedures in 2024 alone, a 50% volume increase since 2018. Endoscopic exams... BOSTON-( BUSINESS WIRE )-AcuityMD today announced it has launched AcuityMD for Salesforce on Salesforce AppExchange, the leading enterprise marketplace for partner apps and experts, empowering customers to integrate AcuityMD's platform directly with Salesforce to help commercial teams identify opportunities, research and prioritize targets, and hit sales goals faster. AcuityMD combines accurate and precise data, AI-powered insights, and intuitive workflows to help commercial teams move faster a...